Please login to the form below

Not currently logged in
Email:
Password:

Targovax strengthens board of directors

Catherine Wheeler joins from Acetylon Pharmaceutical

Clinical stage company Targovax has added to its board of directors with the appointment of Catherine Wheeler.

Most recently, Wheeler served Acetylon Pharmaceutical as chief medical officer and prior to that she held progressively senior clinical and business development roles at Roche, AstraZeneca and Parexel.

Patrick Vink, chairman of the board at Targovax, said: “We are delighted to welcome Catherine, she brings extensive international oncology expertise and insights that will further strengthen the board.

“She has had a long and distinguished career and has significant experience of bringing innovative oncology treatments to market that will be invaluable as we continue to progress the clinical development of our novel and complementary portfolio of cancer immunotherapies.”

18th April 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....